FDA issued a Warning Letter to Taro Pharmaceuticals, Inc on 2/5/2009 for a previous inspection.
483 Taro Pharmaceuticals Feb 2014

483 Taro Pharmaceuticals Feb 2014

Michael Klapal FDA$119.00 - Available Now

FDA investigators audited the Taro Pharmaceuticals - Brampton, Canada facility and issued inspectional observations (via FDA 483) on 28 Feb 2014.

Product details

  • Category: Human Drugs
  • Inspection end: 28 Feb 2014
  • Location: Brampton, Canada
  • FEI: 3002808384
Add To Cart